Investor’s Toolkit: Key Ratios for Assessing Fulcrum Therapeutics Inc (FULC)’s Performance

Kevin Freeman

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

Fulcrum Therapeutics Inc (NASDAQ: FULC) closed the day trading at $9.85 down -2.57% from the previous closing price of $10.11. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 0.74 million shares were traded. FULC stock price reached its highest trading level at $10.37 during the session, while it also had its lowest trading level at $9.8.

Ratios:

For a better understanding of FULC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.70 and its Current Ratio is at 17.70. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.

On July 29, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4 to $12.

Leerink Partners Upgraded its Market Perform to Outperform on May 23, 2025, while the target price for the stock was maintained at $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’26 when Gould Robert J sold 15,000 shares for $11.87 per share. The transaction valued at 178,089 led to the insider holds 469,864 shares of the business.

Oltmans Curtis Gale sold 3,452 shares of FULC for $44,600 on Dec 15 ’25. The Chief Legal Officer now owns 10,252 shares after completing the transaction at $12.92 per share. On Dec 15 ’25, another insider, CURTIS G OLTMANS, who serves as the Officer of the company, bought 3,452 shares for $13.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FULC now has a Market Capitalization of 649807424 and an Enterprise Value of 339432608.

Stock Price History:

The Beta on a monthly basis for FULC is 3.18, which has changed by 1.3621104 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, FULC has reached a high of $15.74, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -6.51%, while the 200-Day Moving Average is calculated to be 29.64%.

Shares Statistics:

Over the past 3-months, FULC traded about 1.33M shares per day on average, while over the past 10 days, FULC traded about 826840 shares per day. A total of 65.97M shares are outstanding, with a floating share count of 59.87M. Insiders hold about 9.27% of the company’s shares, while institutions hold 67.42% stake in the company. Shares short for FULC as of 1765756800 were 2994328 with a Short Ratio of 2.25, compared to 1763078400 on 3564671. Therefore, it implies a Short% of Shares Outstanding of 2994328 and a Short% of Float of 6.0700003.

Earnings Estimates

Current recommendations for the stock of the company come from 10.0 analysts. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.21 and low estimates of -$0.33.

Analysts are recommending an EPS of between -$1.13 and -$1.21 for the fiscal current year, implying an average EPS of -$1.17. EPS for the following year is -$1.2, with 10.0 analysts recommending between -$0.85 and -$1.52.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.